Food Allergy Support is now on Twitter. Follow us @FASupport. You may also follow our Tweets in our new global footer at the bottom of the page here at FAS!

FAS has upgraded our forum security. Some members may need to log in again. If you are unable to remember your login information, please email food.allergy.supt@flash.net and we will help you get back in. Thanks for your patience!


Post reply

Warning: this topic has not been posted in for at least 365 days.
Unless you're sure you want to reply, please consider starting a new topic.
Name:
Email:
Subject:
Message icon:

Verification:
Type the letters shown in the picture
Listen to the letters / Request another image

Type the letters shown in the picture:
Please spell allergy backwards:
Three siblings have blue eyes.  Their names are Suzy, Jack and Bill.  What color are the sister's eyes?:

shortcuts: hit alt+s to submit/post or alt+p to preview

By posting you acknowledge you are subject to our TOS, rules, and guidelines .


Topic Summary

Posted by: LinksEtc
« on: November 02, 2017, 08:34:04 AM »

EpiPen Failures Cited in Seven Deaths This Year, FDA Files Show

Itís not just about the price anymore. Complaints about the lifesaving device have doubled since 2016.

By Anna Edney

‎November‎ ‎02‎, ‎2017‎ ‎4‎:‎00‎ ‎AM

https://www.bloomberg.com/news/articles/2017-11-02/epipen-failures-cited-in-seven-deaths-this-year-fda-files-show


Quote
The FDA received a total of 228 reports of EpiPen or EpiPen Jr. failures during the same time period, according to documents made available as a result of a Freedom of Information Act request. In addition to the deaths, 35 people were hospitalized, according to the reports.

----------------------------------


BTW, regarding FOIA requests ...


"Governments turn tables by suing public records requesters"

By RYAN J. FOLEY

Sep. 17, 2017

https://www.apnews.com/7f6ed0b1bda047339f22789a10f64ac4


Quote
An Oregon parent wanted details about school employees getting paid to stay home. A retired educator sought data about student performance in Louisiana. And college journalists in Kentucky requested documents about the investigations of employees accused of sexual misconduct.

Instead, they got something else: sued by the agencies they had asked for public records.





Posted by: SilverLining
« on: October 27, 2017, 06:24:28 PM »

Posted by: my3guys
« on: September 20, 2017, 09:48:59 PM »

Completely agree momma2!!
Posted by: momma2boys
« on: September 20, 2017, 09:41:09 PM »

My3guys, the thing is, we shouldn't have to wonder about that!
Posted by: my3guys
« on: September 20, 2017, 07:50:11 PM »

This whole thing has me wondering...dangerous I know. I'm thinking back to our incident last year in FL that I posted about. The whole thing definitely appeared like a reaction...first epi relieved symptoms for few minutes. Then they came roaring back. Gave second epi. Symptoms didn't get worse...but didn't subside for a while. By that time he'd been given IV Benadryl and we were in the ambulance. I expected more relief from the epi. It makes me wonder if all the fluid dispensed. It seemed like it worked at the time... we will never know at this point. Guess I should let this go...
Posted by: spacecanada
« on: September 20, 2017, 03:13:20 PM »

Anyone hear if Mylan/Pfizer issued a response to the FDA yet?  Would such a letter be made public?
Posted by: nyguy
« on: September 18, 2017, 10:28:00 AM »

My cousins carry EpiPen and my aunt has been hesitant to switch to Auvi-Q. I know that EpiPen is the titan in the market (market share) and has history, but these revelations are troubling. Sanofi pulled Auvi-Q completely over a couple dozen reports (all lots) and it didn't return to the market for ~18 months.
Posted by: LinksEtc
« on: September 15, 2017, 08:33:43 AM »

I will update the sesame & FDA threads a bit over the next few days.





Posted by: name
« on: September 14, 2017, 01:07:52 PM »

There are times (like now) I feel that the weight of public health bank perseverates on an emotional lifestyle PEANUT-NO PEANUT argument. 

Meanwhile...

  • FDA has massive clusterfudge in the autoinjector market.  No prevention, no competition, all too little, too late after-the-fact.  And where are the FDA at on sesame added to FALCPA? 
  • The ACAA might be amended to allow private right of action.  Yet the social conversation is still on nut bans on planes? 
  • EMS are not remotely in sync with epinephrine administration as convention plans indicate.  Training needs a significant overhaul for the recognition of anaphylaxis (and differentiation in assisted and/or adjunctive drugs when patients have comorbid asthma) to fully implement the intention behind the legislation to allow administration of epinephrine to the most basic scope.
  • Private practice OIT receives little attention compared to FARE/Aimmune CODIT and now FDA qualified health claims are allowed on labels that are based on promising evidence in very select segments.

This is no way directed at my doc.  He lives with the same or more that we do, and he has never fallen into the "PEANUT! PEANUT! PEANUT!" tar pit.
Posted by: ajasfolks2
« on: September 08, 2017, 09:59:12 AM »

Likely going to drive down to son at college and take him another set -- one composed of 2 different lots.  He had 2 sets to begin with, but one is with the travelling athletic people and 1 set with him.

I see now I should get another set to him -- split up from his sister's sets.


Effing Mylan.

Posted by: Janelle205
« on: September 07, 2017, 09:18:47 PM »

Feeling really glad I decided to bite the bullet and go with the non-Mylan generic, though who knows if that is better.

Seriously considering asking for a vial and syringes as a back up. 
Posted by: CMdeux
« on: September 07, 2017, 08:26:44 PM »

 :grouphug:


Just a reminder to... as another poster mentioned upthread-- carry two from different lot numbers if you possibly can.

This is something that most of us old-timers have done for a couple of decades now, since the LAST big kerfuffle and recall back way before Mylan owned the brand, even.  It's a rescue med, and without it operating flawlessly... yeah-- bad, bad things happen.

If a device CANNOT fail you when you need it... plan accordingly.

It'd just really really be nice if we as consumers and patients had a little bit of help-- heck, even just "transparency" I'd settle for that-- from the manufacturers.

 :disappointed:
Posted by: spacecanada
« on: September 07, 2017, 05:11:36 PM »

I'm just beyond words right now.  I figured it was all the same somehow: Mylan and Pfizer.   :rant:

Copying what I wrote in my local allergy group:

Allerject had similarly reported (though never publicly confirmed) dosing defects and recalled every single unit in North America, completely re-engineered their manufacturing process, and came back to market with a more reliable device (in America only). But, if EpiPen did that, we'd have nothing but phials and syringes like AnaKits before - not a situation anyone wants to be in. I'd rather have two devices with a 99% efficiency rate than a phial and syringe.

I just want to cry.  Seriously.  Like I need more anxiety over my allergies right now.  Allerject needs to come back to Canada.  Or we need a miracle cure.  Where can I get one of those?  :'(
Posted by: PurpleCat
« on: September 07, 2017, 04:42:27 PM »

It was on my Facebook Feed today.   :rant: :rant: :rant: :rant:
Posted by: GoingNuts
« on: September 07, 2017, 04:02:15 PM »

I just came on tonpost this.  Livid doesn't even begin to describe what I feel right now.   :rant: